Following recovery from the impact of the\u00a0COVID-19\u00a0pandemic, the European neurostimulation device market will see\u00a0modest growth\u00a0through 2032, driven by ongoing product innovation and a focus on expanding into new indications, increasing the population treatable with these devices, although limited reimbursement and increasing competition from noninvasive alternatives will hinder the pace of market\u00a0growth\u00a0to some extent.<\/p>\n
This Medtech 360 Report provides high-level market metrics for neurostimulation devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2032.<\/p>\n","protected":false},"template":"","class_list":["post-405605","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-neurostimulation-devices","medtech-geography-europe","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/405605","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/405605\/revisions"}],"predecessor-version":[{"id":405923,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/405605\/revisions\/405923"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=405605"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}